Channel Avatar

Grand Rounds in Urology @UCJ9wfEDgPFNQ3Lnrg-u0vCg@youtube.com

21K subscribers - no pronouns :c

Grand Rounds in Urology™ (GRU) is a professional education o


08:26
Combination of Prostate Ablation with Systemic Therapy for Management of Prostate Cancer
18:31
Benefits, Pitfalls and Complications of Rectal Spacers
20:38
GRU - Dr. Baum Interview of Paul Perito
11:54
BioProtect Balloon Implant™ System
19:12
Brian Moran Distinguished Lecture: Mobilizing Moran’s Army from Seed to Shining Seed
19:14
YouTube Surgeons – The Role of Video Learning in Urology
19:24
Renal Ablation Technologies – Impact on the Treatment of Small Renal Masses
18:25
Erectile Dysfunction Treatment – State of the Art Care in 2024
17:57
Early Continence Recovery after Robotic Assisted Radical Prostatectomy: The Role of Prostatic Shape
17:55
Trends of Urinary Diversion: Declining Popularity of Continent Diversion
20:37
Role of Lymphadenectomy in the Surgical Treatment of Clinical Localized Prostate Cancer
24:08
Female Stress Urinary Incontinence 2023
18:59
Robotic Partial Nephrectomy for Complex Cases: Planning the Surgical Strategy
14:40
Update on Penile Implants: Best Practice and Taking Care of Complications
21:06
Making Sense of BPH: Which Treatment for Which Patient – Review of Guidelines for BPH
18:49
Cannabis Use and Male Reproductive Health: Who Knew?
16:24
Stone Volume is a Better Predictor of Spontaneous Stone Passage
20:24
Management of Small Renal Tumors: A Guidelines Based Approach
18:05
Management of Late Complications after Continent Urinary Diversion: Case Presentations
18:19
Simplified Management of Male Genital Pain
22:48
Immortal Field of Longevity in Men’s Health
19:58
Surgical Planning for Robotic Prostatectomy When You are Not the First Surgeon to the Site
18:53
Should MIST be First Line Treatment for BPH?
21:38
Results of a Multi-institutional Randomized Trial of Transrectal vs Transperitoneal Prostate Biopsy
19:15
Testosterone Treatment and Cardiovascular Events among Testosterone Deficient U.S. Veterans
12:48
Micro Ultrasound and MRI of the Prostate
18:24
Ileal Orthotopic Bladder Substitute with an Afferent Tubular Segment: In Memory of Prof. Urs Studer
19:18
Life Expectancy as it Relates to the Treatment of Urologic Cancers
14:59
Functional Urology: A New Subspecialty or Rebranding
15:30
The Artificial Urinary Sphincter in Complex Situations
19:56
Emerging Topics in Ureteroscopy: Pressure, Temperature and Suction
18:25
Game Changers in Prostate Cancer Diagnostics: Imaging Probably Wins the Most
16:54
Prostate Cancer Screening Update
16:12
Management of Neurogenic Lower Urinary Tract Dysfunction: Surgical Options
17:58
Novel Imaging for Renal Mass Characterization
14:55
Testosterone Treatment and Prostate Cancer Risk
21:07
Lasers in Stone Surgery: Principles and Tips/Tricks for Lasers in URS and PCNL
14:01
Priapism: How Do We Manage and How Do We Learn How to Manage in 2024
14:34
Orthotopic Bladder Substitutes in Females: Why We Should Do It
20:27
Immunotherapy in Patients with Localized Renal Cell Carcinoma: The PROSPER Trial and Beyond
14:06
Focal Therapy for Prostate Cancer
10:10
How to Use Natural Ligands to Kill Tumor Stem Cells
09:20
AI in Healthcare: The Hype, The Reality and the Promise
16:55
Artificial Intelligence and Extended Reality for Urology Training
10:11
MRI-invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates
10:53
Integrating Care in APC
10:25
PARPi in mCRPC
10:12
Assessing and Managing Metabolic Risk in Patients with Prostate Cancer
09:23
Financial Toxicity of APC Management
09:23
Putting Germline Testing into Context: A Primer and Current Knowledge
16:53
Perspectives in mCRPC in 2024
10:59
Therapeutic Modalities for BPH
11:19
The Microbiome and Prostate Cancer
13:12
Pathological Aspects of BPH, Prostatitis, and Other Painful Co-occurrences
10:57
Optilume for BPH - Considerations for Use
09:00
Doublets and Triplets: Patient Selection
15:37
Choosing Systemic Therapy for Men with Metastatic Hormone Sensitive Prostate Cancer
09:17
APC Pathways - The Large Urology Group Practice Model
15:07
Treatment of Oligometastatic Prostate Cancer in the Era of PSMA PET Imaging
09:35
Role of Molecular Targeted Imaging in Oligometastatic Disease